• Citer

Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer

par Maurer, Christian;Ferreira, Arlindo A.R.;Martel, Samuel;Lambertini, Matteo ;Pondé, Noam;Aftimos, Philippe ;Azambuja, Evandro ;Piccart-Gebhart, Martine
Référence Breast, 39, page (14-18)
Publication Publié, 2018-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer
Auteur:	Maurer, Christian; Ferreira, Arlindo A.R.; Martel, Samuel; Lambertini, Matteo; Pondé, Noam; Aftimos, Philippe; Azambuja, Evandro; Piccart-Gebhart, Martine
Informations sur la publication:	Breast, 39, page (14-18)
Statut de publication:	Publié, 2018-06
Sujet CREF:	Chirurgie
Mots-clés:	Endocrine resistant
	Endocrine therapy
	Heavily pretreated
	Hormone receptor-positive metastatic breast cancer
	Palbociclib
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0960-9776
	info:doi/10.1016/j.breast.2018.02.027
	info:pii/S0960977618300377
	info:scp/85042193786